CALLISTO PHARMACEUTICALS INC Share-based Payment Arrangement, Expense
CALLISTO PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $15.11 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2012-11-19
- CALLISTO PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $15.11K, a 86.49% decline year-over-year.
- CALLISTO PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-06-30 was $6.21K, a 96.83% decline year-over-year.
- CALLISTO PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2011-09-30 was $111.84K.
- CALLISTO PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2011-06-30 was $195.59K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 193 month | Share-based Payment Arrangement, Expense 196 month |
|---|---|---|---|---|---|
| 2012-09-30 | $15.11K 10-Q · filed 2012-11-19 | $21.32K derived: sum of 2 quarters · filed 2012-11-19 | $109.17K 10-Q · filed 2012-11-19 | $18.07M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $6.21K 10-Q/A · filed 2012-08-28 | $94.06K 10-Q/A · filed 2012-08-28 | $18.06M 10-Q/A · filed 2012-08-28 | ||
| 2011-09-30 | $111.84K 10-Q · filed 2012-11-19 | $307.43K derived: sum of 2 quarters · filed 2012-11-19 | $267.26K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | $195.59K 10-Q/A · filed 2012-08-28 | $172.89K 10-Q/A · filed 2012-08-28 |